MSIF Article on LDN and MS

[Guest guest]

Hi Everyone,

The International Multiple Sclerosis Federation (MSIF) is based in the UK and

publishes in several languages a prestigious periodical called " MS in Focus. "

The latest issue deals with alternative treatments for MS, and it contains this

article about Low Dose Naltrexone:

http://tinyurl.com/msif-ldn-article

The article gives an introduction to LDN and cites several MS-related studies

bearing on its safety and efficacy.

In general, the piece is fairly good, but it concludes with the rather odd

statement that there is no evidence that LDN is superior to any of the

conventional MS treatments. I say " odd " because the author completely overlooks

the fact that LDN is dirt cheap, is administered orally, has minimal side

effects, and can be beneficial in progressive forms of the disease.

Still, the fact that an article about LDN appears at all in such a publication

is a giant step forward in bringing this remarkable remedy to worldwide

attention.

For a more positive perspective on LDN, visit

http://tinyurl.com/ldn-miracle-drug

With best wishes,

Dudley Delany

http://profiles.yahoo.com/dudley_delany